table of content
1 Study Coverage
1.1 CD38 Monoclonal Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Daretuzumab
1.2.3 Isartuximab
1.2.4 Engineered Toxin Body
1.3 Market by Application
1.3.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CD38 Monoclonal Antibody Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global CD38 Monoclonal Antibody Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global CD38 Monoclonal Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global CD38 Monoclonal Antibody Drugs Sales by Region
2.4.1 Global CD38 Monoclonal Antibody Drugs Sales by Region (2017-2022)
2.4.2 Global Sales CD38 Monoclonal Antibody Drugs by Region (2023-2028)
2.5 Global CD38 Monoclonal Antibody Drugs Revenue by Region
2.5.1 Global CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2022)
2.5.2 Global CD38 Monoclonal Antibody Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global CD38 Monoclonal Antibody Drugs Sales by Manufacturers
3.1.1 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CD38 Monoclonal Antibody Drugs in 2021
3.2 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers
3.2.1 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibody Drugs Revenue in 2021
3.3 Global CD38 Monoclonal Antibody Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global CD38 Monoclonal Antibody Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CD38 Monoclonal Antibody Drugs Sales by Type
4.1.1 Global CD38 Monoclonal Antibody Drugs Historical Sales by Type (2017-2022)
4.1.2 Global CD38 Monoclonal Antibody Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
4.2 Global CD38 Monoclonal Antibody Drugs Revenue by Type
4.2.1 Global CD38 Monoclonal Antibody Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global CD38 Monoclonal Antibody Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
4.3 Global CD38 Monoclonal Antibody Drugs Price by Type
4.3.1 Global CD38 Monoclonal Antibody Drugs Price by Type (2017-2022)
4.3.2 Global CD38 Monoclonal Antibody Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global CD38 Monoclonal Antibody Drugs Sales by Application
5.1.1 Global CD38 Monoclonal Antibody Drugs Historical Sales by Application (2017-2022)
5.1.2 Global CD38 Monoclonal Antibody Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
5.2 Global CD38 Monoclonal Antibody Drugs Revenue by Application
5.2.1 Global CD38 Monoclonal Antibody Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global CD38 Monoclonal Antibody Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
5.3 Global CD38 Monoclonal Antibody Drugs Price by Application
5.3.1 Global CD38 Monoclonal Antibody Drugs Price by Application (2017-2022)
5.3.2 Global CD38 Monoclonal Antibody Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America CD38 Monoclonal Antibody Drugs Market Size by Type
6.1.1 North America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
6.1.2 North America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
6.2 North America CD38 Monoclonal Antibody Drugs Market Size by Application
6.2.1 North America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
6.2.2 North America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
6.3 North America CD38 Monoclonal Antibody Drugs Market Size by Country
6.3.1 North America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
6.3.2 North America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe CD38 Monoclonal Antibody Drugs Market Size by Type
7.1.1 Europe CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
7.1.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
7.2 Europe CD38 Monoclonal Antibody Drugs Market Size by Application
7.2.1 Europe CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
7.2.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
7.3 Europe CD38 Monoclonal Antibody Drugs Market Size by Country
7.3.1 Europe CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
7.3.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Type
8.1.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Application
8.2.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Region
8.3.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America CD38 Monoclonal Antibody Drugs Market Size by Type
9.1.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
9.1.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
9.2 Latin America CD38 Monoclonal Antibody Drugs Market Size by Application
9.2.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
9.2.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
9.3 Latin America CD38 Monoclonal Antibody Drugs Market Size by Country
9.3.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
9.3.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Type
10.1.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Application
10.2.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Country
10.3.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson
11.1.1 Johnson Corporation Information
11.1.2 Johnson Overview
11.1.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Corporation Information
11.3.2 Takeda Pharmaceutical Company Overview
11.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Pharmaceutical Company Recent Developments
11.4 CASI Pharmaceutical Company
11.4.1 CASI Pharmaceutical Company Corporation Information
11.4.2 CASI Pharmaceutical Company Overview
11.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CASI Pharmaceutical Company Recent Developments
11.5 Mab Biopharma
11.5.1 Mab Biopharma Corporation Information
11.5.2 Mab Biopharma Overview
11.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mab Biopharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CD38 Monoclonal Antibody Drugs Industry Chain Analysis
12.2 CD38 Monoclonal Antibody Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CD38 Monoclonal Antibody Drugs Production Mode & Process
12.4 CD38 Monoclonal Antibody Drugs Sales and Marketing
12.4.1 CD38 Monoclonal Antibody Drugs Sales Channels
12.4.2 CD38 Monoclonal Antibody Drugs Distributors
12.5 CD38 Monoclonal Antibody Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 CD38 Monoclonal Antibody Drugs Industry Trends
13.2 CD38 Monoclonal Antibody Drugs Market Drivers
13.3 CD38 Monoclonal Antibody Drugs Market Challenges
13.4 CD38 Monoclonal Antibody Drugs Market Restraints
14 Key Findings in The Global CD38 Monoclonal Antibody Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
